Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Compare index funds with the lowest expense ratios for retirement in 2024 to minimize fees while pursuing solid returns. Find your top pick today.
27,177 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A Google-backed pilot is testing a portal-like model that surfaces MLS-listed homes via search, changing how buyers a...
Anthropic's Mythos stirred AI headlines and sent one cybersecurity stock soaring. This article breaks down whether PA...
A nuclear startup teams with a national lab to speed up reactor design using AI. This piece breaks down what it could...
Bitcoin edges lower as institutions redraw access pathways. Traders brace for next week’s catalysts, with Wall Street...
Earnings season isn’t fading—it's evolving. This week’s earnings reports watch this picks three widely followed names...
A clear guide to understanding the 2026 earnings transcript and turning quarterly numbers into actionable investing i...
As AI accelerators push data centers to new speeds, investors who understood the shift decade ago are reaping outsize...
Lululemon is set to report its Q1 results tonight as margins, growth mix, and international exposure take center stag...
New data in 2026 cast doubt on the notion that ditching college ‘more secure’ automatically leads to a stable career,...
Neura secures strategic funding and announces key partnerships to build Emotional AI with memory that persists across...